AAAAAA

   
Results: 1-12 |
Results: 12
The reduction of myocardial damage and leukocyte polymorphonuclear accumulation following coronary artery occlusion by the tyrosine kinase inhibitor tyrphostin AG 556
Authors: Altavilla, D Squadrito, F Campo, GM Saitta, A Squadrito, G Quartarone, C Deodato, B Arlotta, M Ferlito, M Minutoli, L Tringali, M Urna, G Sardella, A Caputi, AP
Citation: D. Altavilla et al., The reduction of myocardial damage and leukocyte polymorphonuclear accumulation following coronary artery occlusion by the tyrosine kinase inhibitor tyrphostin AG 556, LIFE SCI, 67(21), 2000, pp. 2615-2629
Tacrolimus limits polymorphonuclear leucocyte accumulation and protects against myocardial ischaemia-reperfusion injury
Authors: Squadrito, F Altavilla, D Squadrito, G Saitta, A Deodato, B Arlotta, M Minutoli, L Quartarone, C Ferlito, M Caputi, AP
Citation: F. Squadrito et al., Tacrolimus limits polymorphonuclear leucocyte accumulation and protects against myocardial ischaemia-reperfusion injury, J MOL CEL C, 32(3), 2000, pp. 429-440
IRFI 042, a novel dual vitamin E-like antioxidant, inhibits activation of nuclear factor-kappa B and reduces the inflammatory response in myocardial ischaemia-reperfusion injury
Authors: Altavilla, D Deodato, B Campo, GM Arlotta, M Miano, M Squadrito, G Saitta, A Cucinotta, D Ceccarelli, S Ferlito, M Tringali, M Minutoli, L Caputi, AP Squadrito, F
Citation: D. Altavilla et al., IRFI 042, a novel dual vitamin E-like antioxidant, inhibits activation of nuclear factor-kappa B and reduces the inflammatory response in myocardial ischaemia-reperfusion injury, CARDIO RES, 47(3), 2000, pp. 515-528
Protective effects of Cyclosporin-A in splanchnic artery occlusion shock
Authors: Squadrito, F Altavilla, D Squadrito, G Ferlito, M Deodato, B Arlotta, M Minutoli, L Campo, GM Bova, A Quartarone, C Urna, G Sardella, A Saitta, A Caputi, AP
Citation: F. Squadrito et al., Protective effects of Cyclosporin-A in splanchnic artery occlusion shock, BR J PHARM, 130(2), 2000, pp. 339-344
Effect of sulfatide on acute lung injury during endotoxemia in rats
Authors: Squadrito, F Bagnato, G Altavilla, D Ferlito, M Campo, GM Squadrito, G Urna, G Sardella, A Arlotta, M Minutoli, L Quartarone, C Saitta, A Caputi, AP
Citation: F. Squadrito et al., Effect of sulfatide on acute lung injury during endotoxemia in rats, LIFE SCI, 65(24), 1999, pp. 2541-2552
The lazaroid, U-74389G, inhibits inducible nitric oxide synthase activity,reverses vascular failure and protects against endotoxin shock
Authors: Altavilla, D Squadrito, F Campo, GM Squadrito, G Arlotta, M Urna, G Sardella, A Quartarone, C Saitta, A Caputi, AP
Citation: D. Altavilla et al., The lazaroid, U-74389G, inhibits inducible nitric oxide synthase activity,reverses vascular failure and protects against endotoxin shock, EUR J PHARM, 369(1), 1999, pp. 49-55
Cyclosporin-A reduces leukocyte accumulation and protects against myocardial ischaemia reperfusion injury in rats
Authors: Squadrito, F Altavilla, D Squadrito, G Saitta, A Campo, GM Arlotta, M Quartarone, C Ferlito, M Caputi, AP
Citation: F. Squadrito et al., Cyclosporin-A reduces leukocyte accumulation and protects against myocardial ischaemia reperfusion injury in rats, EUR J PHARM, 364(2-3), 1999, pp. 159-168
Cardioprotection by the phytoestrogen genistein in experimental myocardialischaemia-reperfusion injury
Authors: Deodato, B Altavilla, D Squadrito, G Campo, GM Arlotta, M Minutoli, L Saitta, A Cucinotta, D Calapai, G Caputi, AP Miano, M Squadrito, F
Citation: B. Deodato et al., Cardioprotection by the phytoestrogen genistein in experimental myocardialischaemia-reperfusion injury, BR J PHARM, 128(8), 1999, pp. 1683-1690
Adrenocorticotropin reverses vascular dysfunction and protects against splanchnic artery occlusion shock
Authors: Squadrito, F Guarini, S Altavilla, D Squadrito, G Campo, GM Arlotta, M Quartarone, C Saitta, A Cucinotta, D Bazzani, C Cainazzo, MM Mioni, C Bertolini, A Caputi, AP
Citation: F. Squadrito et al., Adrenocorticotropin reverses vascular dysfunction and protects against splanchnic artery occlusion shock, BR J PHARM, 128(3), 1999, pp. 816-822
Recombinant human erythropoietin inhibits iNOS activity and reverts vascular dysfunction in splanchnic artery occlusion shock
Authors: Squadrito, F Altavilla, D Squadrito, G Campo, GM Arlotta, M Quartarone, C Saitta, A Caputi, AP
Citation: F. Squadrito et al., Recombinant human erythropoietin inhibits iNOS activity and reverts vascular dysfunction in splanchnic artery occlusion shock, BR J PHARM, 127(2), 1999, pp. 482-488
Tacrolimus suppresses tumour necrosis factor-alpha and protects against splanchnic artery occlusion shock
Authors: Squadrito, F Altavilla, D Squadrito, G Ferlito, M Campo, GM Arlotta, M Grimaldi, S Quartarone, C Saitta, A Caputi, AP
Citation: F. Squadrito et al., Tacrolimus suppresses tumour necrosis factor-alpha and protects against splanchnic artery occlusion shock, BR J PHARM, 127(2), 1999, pp. 498-504
Sulfatide reduces leucocyte accumulation and reverts vascular failure in splanchnic artery occlusion shock
Authors: Squadrito, F Altavilla, D Squadrito, G Campo, GM Arlotta, M Quartarone, C Minutoli, L Ferlito, M Saitta, A Caputi, AP
Citation: F. Squadrito et al., Sulfatide reduces leucocyte accumulation and reverts vascular failure in splanchnic artery occlusion shock, EUR J PHARM, 361(1), 1998, pp. 101-108
Risultati: 1-12 |